By staff writers

August 3, 2018 -- Preclinical imaging developer MILabs has completed the installation of its dual-energy, ultrahigh-resolution CT scanner at the Hebrew University of Jerusalem in Israel.

Principal investigator Galia Blum, PhD, and colleagues at the university's Institute of Drug Research will use the device to visualize disease-detecting probes that have been labeled with either gold or iodine. This technique will help the group in its search for new drugs aimed at managing pathologies such as cancer and autoimmune diseases, the company said.

Copyright © 2018

To read this and get access to all of the exclusive content on create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking